FDA approves new 'female Viagra' injection targeting brain receptors
Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Flair also analysed dozens of open letters published by alumnae of private schools who complained…